Study of RP-3500 (Camonsertib) With Niraparib or Olaparib in Advanced Solid Tumors
Clinical trial NCT04972110 · TERMINATED
Trial details
- NCT number
- NCT04972110
- Sponsor
- Repare Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-21
- Primary completion
- 2024-11-13
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.